Appendix A – Description of the CVD panels

The deCODE MI™ test is offered by deCODE genetics (Reykjavik, Iceland) as a LDT on blood and buccal samples in a single CLIA-certified laboratory as a risk factor for myocardial infarction (MI). According to the deCODE website (www.decode.com), ordering the test requires submission of an informed consent form completed by the patient and ... ................
................